StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday morning. COLL has been the subject of a number of other reports. Needham & Company LLC reiterated a buy rating and issued a $40.00 price target on shares of Collegium Pharmaceutical […]
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) will post its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect Collegium Pharmaceutical to post earnings of $1.37 per share for the quarter. Collegium Pharmaceutical has set its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can […]
Collegium Pharmaceutical (NASDAQ:COLL) Trading Up 3 8% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
STOUGHTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical